These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38204512)

  • 1. Impact of Multidisciplinary Heart Failure Clinic on Guideline-Directed Medical Therapy and Clinical Outcomes.
    Tan SS; Hisham SA; Bin Abdul Malek AM; Lik CP; Lau GSK; Bin Abdul Ghapar AK
    Can J Hosp Pharm; 2024; 77(1):e3364. PubMed ID: 38204512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multispecialty multidisciplinary input into comorbidities along with treatment optimisation in heart failure reduces hospitalisation and clinic attendance.
    Essa H; Walker L; Mohee K; Oguguo C; Douglas H; Kahn M; Rao A; Bellieu J; Hadcroft J; Hartshorne-Evans N; Bliss J; Akpan A; Wong C; Cuthbertson DJ; Sankaranarayanan R
    Open Heart; 2022 Jul; 9(2):. PubMed ID: 35858706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline-directed medical therapy in heart failure patients: impact of focused care provided by a heart failure clinic in comparison to general cardiology out-patient department.
    Joseph J; P S S; James J; Abraham S; Abdullakutty J
    Egypt Heart J; 2020 Aug; 72(1):53. PubMed ID: 32833163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of a multidisciplinary heart failure clinic in optimization of guideline-directed medical therapy: HF-optimize.
    Diederich T; Burdorf A; Pozehl B; Bowman S; Ferguson K; Holder K; Alonso W; Stoller D; Lundgren S
    Heart Lung; 2023; 57():95-101. PubMed ID: 36088681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the prescribing practice of guideline-directed medical therapy among ambulatory chronic heart failure patients.
    Parajuli DR; Shakib S; Eng-Frost J; McKinnon RA; Caughey GE; Whitehead D
    BMC Cardiovasc Disord; 2021 Feb; 21(1):104. PubMed ID: 33602125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a multidisciplinary inpatient heart failure service and its association with hospitalized patient outcomes: First experience from the Middle East and North Africa region.
    Manla Y; Ghalib HH; Badarin FA; Ferrer R; Lee-St John T; Abdalla K; Soliman M; Gabra G; Bader F
    Heart Lung; 2023; 61():92-97. PubMed ID: 37196385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction.
    Balakumaran K; Patil A; Marsh S; Ingrassia J; Kuo CL; Jacoby DL; Arora S; Soucier R
    Int J Cardiol Heart Vasc; 2019 Mar; 22():1-5. PubMed ID: 30480083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year mortality outcomes and hospital readmissions of patients admitted with acute heart failure: Data from the Trivandrum Heart Failure Registry in Kerala, India.
    Harikrishnan S; Sanjay G; Agarwal A; Kumar NP; Kumar KK; Bahuleyan CG; Vijayaraghavan G; Viswanathan S; Sreedharan M; Biju R; Rajalekshmi N; Nair T; Suresh K; Jeemon P
    Am Heart J; 2017 Jul; 189():193-199. PubMed ID: 28625377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction.
    Nauta JF; Santema BT; van der Wal MHL; Koops A; Warink-Riemersma J; van Dijk K; Inkelaar F; Prückl S; Suwijn J; van Deursen VM; Meijers WC; Coster J; Westenbrink BD; de Boer RA; Hummel Y; van Melle J; van Veldhuisen DJ; van der Meer P; Voors AA
    Neth Heart J; 2021 Jul; 29(7-8):383-393. PubMed ID: 34125353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings.
    Mazza A; Townsend DM; Torin G; Schiavon L; Camerotto A; Rigatelli G; Cuppini S; Minuz P; Rubello D
    Biomed Pharmacother; 2020 Oct; 130():110596. PubMed ID: 34321170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community.
    Dunlay SM; Killian JM; Roger VL; Schulte PJ; Blecker SB; Savitz ST; Redfield MM
    J Card Fail; 2022 Oct; 28(10):1500-1508. PubMed ID: 35902033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Socioeconomic Status on Mortality and Readmission in Patients With Heart Failure With Reduced Ejection Fraction: The ARIC Study.
    Mathews L; Ding N; Mok Y; Shin JI; Crews DC; Rosamond WD; Newton AK; Chang PP; Ndumele CE; Coresh J; Matsushita K
    J Am Heart Assoc; 2022 Sep; 11(18):e024057. PubMed ID: 36102228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.
    Kocabaş U; Ergin I; Kıvrak T; Yılmaz Öztekin GM; Tanık VO; Özdemir İ; Avcı Demir F; Doğduş M; Şen T; Altınsoy M; Üstündağ S; Urgun ÖD; Sinan ÜY; Uygur B; Yeni M; Özçalık E
    ESC Heart Fail; 2023 Dec; 10(6):3677-3689. PubMed ID: 37804042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.
    Gehlken C; Screever EM; Suthahar N; van der Meer P; Westenbrink BD; Coster JE; Van Veldhuisen DJ; de Boer RA; Meijers WC
    ESC Heart Fail; 2021 Aug; 8(4):2458-2466. PubMed ID: 34085774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-based care for the specialized management of heart failure: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(17):1-42. PubMed ID: 23074521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 20. Titration of medications and outcomes in multi-ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New Zealand.
    Teng TK; Tay WT; Ouwerkerk W; Tromp J; Richards AM; Gamble G; Greene SJ; Yiu KH; Poppe K; Ling LH; Lund M; Sim D; Devlin G; Loh SY; Troughton R; Ren QW; Jaufeerally F; Lee SGS; Tan RS; Soon DKN; Leong G; Ong HY; Yeo DPS; Lam CSP; Doughty RN
    ESC Heart Fail; 2023 Apr; 10(2):1280-1293. PubMed ID: 36722315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.